Views & Analysis
Market Access/ Podcast/ Video/ Views & Analysis/ Views and analysis
Galapagos UK’s Michael Smyth on RNA-based tech: the pharmaphorum podcast
mike.smith@pharmaphorum.com
Galapagos, HTA, Michael Smyth, podcast, rna
0 Comment
Deep Dive/ Market Access/ Views & Analysis/ Views and analysis
Deep Dive: Market Access
mike.hammerton@pharmaphorum.com
Boehringer Ingelheim, Brexit, Deep Dive, digital health, HTA, market access, NICE, patient centricity, patient engagement, sales
0 Comment
Market Access/ Views & Analysis/ Views and analysis
The next five years of NICE: Challenges, opportunities, and the future of technology assessment
Amanda Barrell
digital health, health inequality, health technology evaluation, mental health, NICE
0 Comment
Market Access/ Views & Analysis/ Views and analysis
Three pillars of post-pandemic launch excellence
Market Access/ Views & Analysis/ Views and analysis
Global impact: How regulatory affairs is shaping development of cutting-edge pharma innovation
mike.hammerton@pharmaphorum.com
Astellas, market access, Regulatory affairs
0 Comment
Market Access/ Views & Analysis/ Views and analysis
NICE methods and process review aims to create fertile ground for innovation
Market Access/ Views & Analysis/ Views and analysis
The Brexit deal; shot in the arm or kick in the teeth for the pharma sector?
Digital/ Market Access/ R&D/ Views & Analysis/ Views & Analysis/ Views & Analysis/ Views and analysis
Life sciences must become cloud-first to seize the science of tomorrow
mike.hammerton@pharmaphorum.com
Accenture, Cloud, data
0 Comment